Enolen is currently being studied in a Phase 1 trial evaluating its safety, tolerability and preliminary efficacy for localized sustained delivery of enzalutamide into the prostate. Alessa expects to ...

Discover how High-Intensity Focused Ultrasound (HIFU) treatment is revolutionizing care for prostate cancer and tumours with ...

NEW HAVEN, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of therapies called RIPTAC™ Therapeutics, today announced that ...

LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, ...

Apr. 24, 2023 7:30 AM ETLantheus Holdings, Inc. (LNTH), PNT Lantheus in-licensed exclusive worldwide commercialization rights (excluding certain Asian territories) to 177 Lu-PNT2002 from POINT in ...

PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...

Every prostate cancer journey begins with a clear understanding of the diagnosis. This isn’t a “one-size-fits-all” disease, and treatment plans are highly personalized. “When we’re evaluating a case ...

Prostate cancer is common in men, with risk factors including age, family history, and genetic mutations. Early-stage cancer often lacks symptoms. Diagnosis involves PSA tests, digital rectal exams, ...

Former President Joe Biden, 82, is facing critical treatment decisions after revealing an aggressive prostate cancer diagnosis just days after doctors discovered a “small nodule” in his prostate. With ...